2MO EO2401 (EO) therapeutic vaccine for patients (pts) with adrenocortical carcinoma (ACC) and malignant pheochromocytoma/paraganglioma (MPP): Phase I/II SPENCER study
- Resource Type
- Source
- Annals of Oncology. 33:S545-S546
- Subject
Oncology Hematology - Language
- ISSN
- 0923-7534